Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT04687020
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-10-19
First Post:
2020-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
Sponsor:
NS Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2032-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-16
First Submit QC Date:
None
Study First Post Date:
2020-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-18
Last Update Post Date:
2022-10-19
Last Update Post Date Type:
ACTUAL